Autoimmune and Inflammatory Disorders Research
Autoimmune and Inflammatory Disorders Research is a research topic within Hematology. Science Explorer counts 24k research works in it since 1950. 16.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on hemophagocytic syndromes, particularly hemophagocytic lymphohistiocytosis (HLH) and related disorders such as macrophage activation syndrome. It covers topics including diagnostic guidelines, therapeutic approaches, genetic mutations, cytokine involvement, and treatment efficacy in both pediatric and adult patients with various forms of the syndrome. The cluster also explores the association of these syndromes with conditions like juvenile idiopathic arthritis and provides insights into the pathogenesis, classification criteria, and long-term outcomes.
- Hemophagocytic Lymphohistiocytosis
- Juvenile Idiopathic Arthritis
- Macrophage Activation Syndrome
- Cytotoxic Granules Fusion
- Interleukin-1 Blockade
- Perforin Gene Mutations
- Systemic-onset Juvenile Idiopathic Arthritis
- Etoposide Treatment
- Familial Hemophagocytic Lymphohistiocytosis
- HLH-2004 Guidelines
- Research works
- 24k fractional, since 1950
- In the world top 10%
- 4k per year above
- Top-10% rate
- 16.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +33% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Autoimmune and Inflammatory Disorders Research research?
By volume, the United States and China publish the most (862 and 656 works in 2022–2025).
By volume, 2022–2025
- 1 United States 862 works
- 2 China 656 works
- 3 United Kingdom 296 works
- 4 India 268 works
- 5 Türkiye 239 works
- 6 Italy 224 works
- 7 Japan 213 works
- 8 Germany 186 works
- 9 France 185 works
- 10 Brazil 150 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Autoimmune and Inflammatory Disorders Research research?
By volume in 2022–2025, Hacettepe University publishes the most Autoimmune and Inflammatory Disorders Research research, followed by Sağlık Bilimleri Üniversitesi and University College London.
By volume, 2022–2025
- 1 Hacettepe UniversityTürkiye 24 works
- 2 Sağlık Bilimleri ÜniversitesiTürkiye 18 works
- 3 University College LondonUnited Kingdom 17 works
- 4 Capital Medical UniversityChina 17 works
- 5 Cincinnati Children's Hospital Medical CenterUnited States 15 works
- 6 Charité - Universitätsmedizin BerlinGermany 15 works
- 7 Sichuan UniversityChina 15 works
- 8 Istituti di Ricovero e Cura a Carattere ScientificoItaly 14 works
- 9 Istanbul University-CerrahpaşaTürkiye 14 works
- 10 Post Graduate Institute of Medical Education and ResearchIndia 14 works
Who are the leading researchers in Autoimmune and Inflammatory Disorders Research?
The most-cited researchers publishing on Autoimmune and Inflammatory Disorders Research include Stefan Schreiber.
- 1 Stefan Schreiber Germany 2.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Autoimmune and Inflammatory Disorders Research research done?
The largest centres of Autoimmune and Inflammatory Disorders Research research in 2022–2025 are Beijing (China), London (United Kingdom), Paris (France) and Istanbul (Türkiye). Among places with at least 20 works in it, it is an unusually large share of all research in Tunis and Cincinnati.
Largest cities, 2022–2025
Where it is the local speciality
- TunisTN · 27.6 works8.5×
- CincinnatiUS · 27.3 works7.2×
Location quotient: how much more of its research is in Autoimmune and Inflammatory Disorders Research than the world average.
Where is the best place to study Autoimmune and Inflammatory Disorders Research?
Among universities, judged by research, Istanbul University-Cerrahpaşa, Hacettepe University and Capital Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Istanbul University-CerrahpaşaTürkiye | 62.9 | 15.1% | 11.7× | 14 | +167.9% |
| 2 | Hacettepe UniversityTürkiye | 59.1 | 7.2% | 9.8× | 24 | +72.0% |
| 3 | Capital Medical UniversityChina | 52.6 | 17.6% | 6.0× | 17 | +85.2% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 52.1 | 28.2% | 2.5× | 12 | +190.6% |
| 5 | Sağlık Bilimleri ÜniversitesiTürkiye | 48.9 | 9.0% | 6.8× | 18 | — |
| 6 | University of Alabama at BirminghamUnited States | 48.2 | 23.5% | 5.3× | 12 | +50.1% |
| 7 | Post Graduate Institute of Medical Education and ResearchIndia | 46.3 | 3.1% | 8.7× | 14 | +146.7% |
| 8 | Harvard UniversityUnited States | 45.9 | 28.8% | 2.0× | 12 | +30.1% |
| 9 | University of PaduaItaly | 45.2 | 22.4% | 3.6× | 14 | +20.8% |
| 10 | Shanghai Jiao Tong UniversityChina | 44.2 | 26.1% | 0.9× | 10 | +265.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Autoimmune and Inflammatory Disorders Research research growing?
Output in 2018–2022 was 33% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Autoimmune and Inflammatory Disorders Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.